Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7,065 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells.
Harada K, Supriatno, Kawaguchi S, Tomitaro O, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. In Vivo. 2004 Jul-Aug;18(4):449-55. In Vivo. 2004. PMID: 15369183
High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
Harada K, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Anticancer Res. 2006 Mar-Apr;26(2B):1615-9. Anticancer Res. 2006. PMID: 16619581
High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Anticancer Res. 2005 May-Jun;25(3c):2471-5. Anticancer Res. 2005. PMID: 16080478
PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.
Yoshida K, Okamura H, Ochiai K, Hoshino Y, Haneji T, Yoshioka M, Hinode D, Yoshida H. Yoshida K, et al. Among authors: yoshida h. Mol Cell Endocrinol. 2012 Sep 25;361(1-2):99-105. doi: 10.1016/j.mce.2012.03.019. Epub 2012 Apr 5. Mol Cell Endocrinol. 2012. PMID: 22484461
Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
Harada K, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Oncol Rep. 2006 Jun;15(6):1417-23. Oncol Rep. 2006. PMID: 16685374
Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K, Supriatno, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Int J Oncol. 2005 Dec;27(6):1489-97. Int J Oncol. 2005. PMID: 16273203
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y, Harada K, Ferdous T, Yoshida H. Itashiki Y, et al. Among authors: yoshida h. Anticancer Res. 2007 Jul-Aug;27(4B):2365-75. Anticancer Res. 2007. PMID: 17695527
S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Harada K, Supriatno, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Int J Oncol. 2007 Feb;30(2):365-74. Int J Oncol. 2007. PMID: 17203218
Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells.
Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H, Sato M. Onoue T, et al. Among authors: yoshida h. Int J Oncol. 2006 Nov;29(5):1133-8. Int J Oncol. 2006. PMID: 17016644
S-1, an oral fluoropyrimidine anti-cancer agent, enhanced radiosensitivity in a human oral cancer cell line in vivo and in vitro: involvement possibility of inhibition of survival signal, Akt/PKB.
Harada K, Kawaguchi S, Supriatno, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Cancer Lett. 2005 Aug 26;226(2):161-168. doi: 10.1016/j.canlet.2004.12.048. Cancer Lett. 2005. PMID: 16134238
7,065 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback